Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane OxygenationBenedikt Schrage, Dirk Westermann, Mathew S. Lopes et al.|Circulation|2020Cited by 502
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarctionMark Luedde, Norbert Frey, Matthias Lutz et al.|Cardiovascular Research|2014Cited by 316
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosisFabian Benz, Tom Luedde, Christoph Roderburg et al.|Experimental & Molecular Medicine|2013Cited by 172
Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and SepsisChristoph Roderburg, Tom Luedde, Mark Luedde et al.|PLoS ONE|2013Cited by 158